cirsimaritin has been researched along with gosogliptin in 1 studies
Studies (cirsimaritin) | Trials (cirsimaritin) | Recent Studies (post-2010) (cirsimaritin) | Studies (gosogliptin) | Trials (gosogliptin) | Recent Studies (post-2010) (gosogliptin) |
---|---|---|---|---|---|
49 | 0 | 21 | 8 | 3 | 6 |
Protein | Taxonomy | cirsimaritin (IC50) | gosogliptin (IC50) |
---|---|---|---|
Dipeptidyl peptidase 4 | Homo sapiens (human) | 1.6564 | |
Dipeptidyl peptidase 8 | Homo sapiens (human) | 7 | |
Dipeptidyl peptidase 9 | Homo sapiens (human) | 5.98 | |
Dipeptidyl peptidase 2 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
1 review(s) available for cirsimaritin and gosogliptin
Article | Year |
---|---|
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |